ArticleHeliyon2023
Histomorphometric evaluation of 3D printed graphene oxide-enriched poly(ε-caprolactone) scaffolds for bone regeneration.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Unleashing innovation: 3D-printed biomaterials in bone tissue engineering for repairing femur and tibial defects in animal models - a systematic review and meta-analysis.Frontiers in bioengineering and biotechnology · 2024Pooled it
- Optimized 3D-Printed Polylactic Acid/Graphene Oxide Scaffolds for Enhanced Bone Regeneration.Bioengineering (Basel, Switzerland) · 2025Article
- Graphene Oxide in Bone Regenerative Engineering: Current Challenges and Future Perspectives.ACS bio & med chem Au · 2025Review
- Graphene in 3D Bioprinting.Journal of functional biomaterials · 2024Review
- Mass Spectrometry Imaging of Biomaterials.Materials (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Restoring large boney defects using bone grafts alone is an unpredictable procedure. Biodegradable polymeric scaffolds suffer rapid biodegradation and lack sufficient osteo-conductivity. The aim of this study was to histomorphometrically evaluate three-dimensional printed graphene oxide-enriched poly(ε-caprolactone) (PCL) scaffolds for bone regeneration in a rabbit defect model using two different concentrations of graphene oxide. Basic characteristic properties and mount of new bone regeneration formation were evaluated. Methods: two concentrations of graphene oxide (1 and 3 wt%) were added to PCL scaffolds using hot blind technique while pure PCL scaffolds served as a control. Laboratory characterization included scanning electron microscopy (SEM), x-ray diffraction analysis (XRD), contact angle, internal porosity, in addition to density measurements. All scaffolds were subjected to biodegradation evaluation and cell cytotoxicity test. In vivo bone regeneration was evaluated in the tibia defect of a rabbit model by measuring the amount of new bone formation (n = 15, ά = 0.05). Results: SEM images showed slight reduction in pore size and increase in filament width of scaffolds with increasing GO contents. However, the printed scaffolds matched well with the dimensions of the original design. XRD patterns revealed characteristic peaks identifying microstructure of scaffolds. Addition of GO increased crystallinity of the scaffolds. The contact angle and porosity readings indicated reduction in measurements with increased content of GO indicating improved wetting properties while the density followed an opposing pattern. Higher biodegradability values were associated with higher GO content resulting in acceleration of observed biodegradation. The results of cytotoxicity test showed reduction in cell viability with higher GO content. Bone regeneration was significantly enhanced for 1 wt% GO scaffolds compared to other groups as was evident by higher bone density observed in x-ray images and higher amount of new bone formation observed at different time intervals. Significance: Graphene oxide improved the physical and biological properties of PCL scaffolds and significantly enhanced new bone regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.